Shanghai Pharmaceutical In Deals With 69 MNCs
This article was originally published in PharmAsia News
Executive Summary
Shanghai Pharmaceutical Co. Inc.struck deals with 69 multinational drug companies including Johnson & Johnson, Pfizer Inc. and Merck & Co., offering drugs totaling more than RMB 20 billion and making the Chinese drug giant first in China's device and high-end pharmaceutical markets, as well as second in the vaccine market